MOREPENLAB — Morepen Laboratories Share News
0.000.00%
Last trade - 00:00- IN₹67.69bn
- IN₹69.24bn
- IN₹18.06bn
India's Morepen Laboratories gains on U.S. FDA submission for Sitagliptin tablets
Brief: Morepen Laboratories Submits First U.S. ANDA For Sitagliptin Tablets USP In Three Strengths
Brief: Morepen Laboratories Ltd June-Quarter Consol Net Profit 563.5 Million Rupees
India's Morepen Laboratories slips after quarterly profit fall
Brief: Morepen Laboratories March-Quarter Consol Net Profit 157 Million Rupees
Brief: Morepen Laboratories Says USFDA Clears Masulkhana API Facility With Nil Form 483 Observations
Brief: Morepen Laboratories Gets Order Worth 8.25 Bln Rupees
India's Morepen Laboratories jumps on 8.25 billion-rupee order win
Brief: Morepen Laboratories Secures 8.25 Billion Rupees CDMO Deal
Brief: Morepen Laboratories Dec-Quarter Consol Net Profit 275.1 Million Rupees
Brief: Morepen Laboratories Says Court Grants Stay On 1.18 Billion Rupees Tax Demand Against Co
Brief: Morepen Laboratories Receives Show Cause Notice For 1.18 Billion Rupees From GST Authority
Brief: Morepen Laboratories Sept-Quarter Consol Net Profit 408.7 Mln Rupees
Brief: Morepen Laboratories Approves 500 Million Rupees Loan From Kookmin Bank
India's Morepen Laboratories rises after unit to form joint venture
Brief: Morepen Laboratories Says Morepen Medipath Forms Joint Venture With Bimedical
Brief: Morepen Laboratories March-Quarter Net Profit 119.1 Mln Rupees
India's Morepen Labs jumps on new drug launches
Brief: Morepen Laboratories - Executes Business Transfer Agreement With Unit Morepen Medtech